Get started
Work

Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Year: 2013
Type: article
Study design: Observational Study
Abstract: Relapse is the primary cause of treatment failure after alloHCT for hematologic malignancies. We describe the presentation, management, and outcomes of children with post-HCT relapse, specifically focusing on post-HCT minimal residual disease (MRD), to improve monitoring and intervention strategies.
DOI: 10.1016/j.bbmt.2012.11.450
Authors: Nirali Shah, Michael J. Borowitz, Nancy Robey, Christopher Gamper, Heather Symons, David Loeb, Alan S. Wayne, Allen Chen
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2012447230
FWCI:
Cites:
Cited by:
Related to: 10